A new study, presented at the United European Gastroenterology, reveals how chronic stress disturbs the balance of gut ...

Proscia has launched two new products which will help to accelerate discovery and development of new therapies and diagnostics. On October 2, 2024, Proscia announced the launch of Concentriq® ...

Radioimmunotherapy (RIT) is a promising cancer treatment gaining recognition in precision oncology. It utilises radiolabelled antibodies to deliver targeted radiation to tumours, with success in ...

A deep-learning model found metabolites and drugs that could be repurposed for non-addictive and non-opioid options to treat chronic pain. Researchers at Kent State University, Cleveland Clinic and ...

Cancer Research UK-funded researchers aim to identify targets for an ovarian cancer vaccine, which could prevent the disease at an early stage. It has been announced that a new study will commence, ...

Researchers have identified underlying KRAS mutations which drive associated risk of particular clinical outcomes. Researchers at Weill Cornell Medicine, New York-Presbyterian and Memorial Sloan ...

Sphere Fluidics have developed the Cyto-Mine® Chroma platform, which provides multiplexing and greater assay flexibility, reducing timelines and cost. On October 1, 2024, Sphere Fluidics announced ...

The success of CAR-Ts in oncology has stoked enthusiasm for developing comparable curative therapies in other disease areas. CellProthera’s Chief Scientific Officer, Ibon Garitaonandia, explains the ...

Results from Pistoia Alliance’s Lab of the Future survey has shared important findings about the challenges life science companies face. The results from The Pistoia Alliance’s Lab of the Future ...

Researchers at the University of California San Diego have discovered two distinct molecular subtypes of Crohn’s disease by studying organoids derived from adult stem cells in the intestine tissue ...

Results from Pistoia Alliance’s Lab of the Future survey has shared important findings about the challenges life science companies face.

In this in-depth Q&A, Mutlu Dogruel, Vice President of AI at Cresset shares his insights surrounding chatbots, retrieval augmented generation and AI hallucinations, to open up new possibilities for ...